Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma - sprookjes - yvandenbroek - TriplyDB

Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma

Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma

http://www.wikidata.org/entity/Q34687224

about

PPAR Ligands Function as Suppressors That Target Biological Actions of HMGB1 Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer Consensus report of the 2015 Weinman International Conference on Mesothelioma Understanding cachexia as a cancer metabolism syndrome Bioanalytical techniques for detecting biomarkers of response to human asbestos exposure Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapies Emerging role of HMGB1 in lung diseases: friend or foe.The association of HMGB1 expression with clinicopathological significance and prognosis in hepatocellular carcinoma: a meta-analysis and literature review.HMGB1 in health and disease.Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxorubicin in breast cancer cells.Clinical significance of serum CA125 in diffuse malignant mesothelioma Malignant pleural mesothelioma: current and future perspectives Prognostic value of HMGB1 in early breast cancer patients under neoadjuvant chemotherapy.Hmgb1 inhibits Klotho expression and malignant phenotype in melanoma cells by activating NF-κB.Serum HMGB1 as a Potential Biomarker for Patients with Asbestos-Related Diseases.Personalized medicine approaches in epilepsy.Prognostic value of several biomarkers for the patients with malignant pleural mesothelioma.HMGB1 overexpression as a prognostic factor for survival in cancer: a meta-analysis and systematic review.Prognostication and monitoring of mesothelioma using biomarkers: a systematic review.A comparison of HMGB1 concentrations between cerebrospinal fluid and blood in patients with neurological disease.Biomarkers for Early Diagnosis and Prognosis of Malignant Pleural Mesothelioma: The Quest Goes on.

P2860

Q26738811-2B941827-CDBD-4F79-A9C5-4BDD5F66BE16 Q26795466-4107FC9C-5433-4DEF-B83A-8CAFF2A255CD Q27908468-3CA31609-129F-4FED-9842-2E2CB205DFBF Q28069390-DBF78FC7-45F4-468F-904B-2840D645C9D9 Q28082088-B688F6DA-27CA-4DFB-9FB8-7534493703F7 Q28395597-E594AEE5-7C87-4A5C-AA65-BB34C7A8442B Q33684145-A5510677-49EC-468F-BA6D-4FFB7B873CE2 Q34428389-75F2BBB0-FD66-49FF-87C9-56379A92349B Q34622835-6C3BF107-4E91-482C-ABF4-BC834C13A217 Q35523700-3AAA725F-3762-4F6E-9280-0A0910787E58 Q36723787-B318C420-534E-45B0-ABFF-28A58EFB778C Q37217764-B856EAE8-6A8E-4AD4-8C45-67D7CB9579A5 Q37321088-4C8C29CC-5829-46B8-A25C-DFC9758BBDE3 Q37697068-1622AD6F-5A6E-4ACA-B6A3-1955F47F1128 Q37700097-2FBBCC12-5D67-4388-8F86-1DD947A5F2DA Q38262011-46E081F7-BEB8-41B4-BB99-A9096B57B494 Q38585167-CA518404-FF53-43F2-8237-9D2D2C84DFF7 Q38890114-7FFA1184-3E81-4A9F-8FAE-A3331FFB780A Q39124644-03B114A0-2D8B-4463-ADDB-18E8409586DB Q40431064-A7242CC9-D0F4-4218-AEEC-9DEFA8A13616 Q55459882-7557D44C-98EC-497E-AB8F-0606357105BE

P2860

Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma

http://www.wikidata.org/entity/Q34687224

description

2013 nî lūn-bûn

@nan

2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma

@ast

Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma

@en

Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma

@nl

type

label

Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma

@ast

Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma

@en

Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma

@nl

prefLabel

Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma

@ast

Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma

@en

Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma

@nl

P1433

Q34687224-D36C7BC6-2A42-4592-A94C-F20CDD556146

P1476

Q34687224-805088ED-0C48-4B45-82CA-50BF004118FA

P2093

Q34687224-3F2DCFB0-0F90-4176-88B2-4F3009A90794

Q34687224-44CEDEE7-984E-4A19-8A9D-9C5308787BF2

Q34687224-6B94AE78-CF1D-4B03-8D62-16E9DE58E5B6

Q34687224-92FCFE09-DBA3-4341-A491-6FC820BA9308

Q34687224-A10B2C25-7422-4867-9338-D2AD4D997319

Q34687224-A18892C8-62F0-4B6A-A74D-EAFD4033FC90

Q34687224-B80EDBEC-455B-4913-9A33-AAF3781CD044

Q34687224-E72BBB12-405C-41B9-BE9C-56BFAD2C10B0

Q34687224-F234433E-AEC4-41F2-BD1F-894DCDA666FC

P2860

Q34687224-02D0D88F-83F6-4EC9-BA96-5CBC76B25E76

Q34687224-1A9AFF99-75F9-4C8C-BE6E-03E56703FCEB

Q34687224-25D892DF-47BE-4665-9993-D5E40EFB621B

Q34687224-2A2D6F0D-4B9E-4DFF-8DA8-DB9C385A0F20

Q34687224-34707B2F-851B-4464-B6FF-B7E1496284B5

Q34687224-4DA00442-03C7-40D7-B23D-31C3199B1199

Q34687224-537B7984-4B36-4C17-9861-99C700117B1E

Q34687224-6D9E6750-B660-4BD1-9F7A-61C5AB41195B

Q34687224-77810F8D-02DE-4195-BFE6-5AA32B94A368

Q34687224-83946D98-F26D-4722-A2CB-25852CB59DCB

P2888

Q34687224-DDBDAD45-37D8-4955-AF76-1B7518F2ED75

P304

Q34687224-4B66C2F2-C2A6-42BA-AB96-61982F70498B

P31

Q34687224-D46C3D14-0507-4927-9E6A-4E4C49A76875

P356

Q34687224-5B5EEA0F-7EED-4E37-A0F3-59AC3C8DC953

P407

Q34687224-9F7236DD-F4B4-422F-9110-3C3ECA195311

P478

Q34687224-ABD09AD7-8D05-4535-AF99-AE628270CE62

P577

Q34687224-A972130F-1806-44B5-8C27-4E0245D8E9C1

P5875

Q34687224-D8B7BD12-18B8-4D93-8AF3-676BA8D3B5EF

P6179

Q34687224-0790FE35-2197-4770-B420-74A4E5FC7334

P698

Q34687224-B5A697E9-F8F9-4220-9A60-EA748B5CBE8A

P932

Q34687224-A38FA541-2737-4184-9698-D14CA11CC7A6

P356

1471-2407-13-205

P1433

P1476

Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma

@en

P2093

Chiharu Tabata

http://www.w3.org/2001/XMLSchema#string

Eisuke Shibata

http://www.w3.org/2001/XMLSchema#string

Eriko Masachika

http://www.w3.org/2001/XMLSchema#string

Koji Mikami

http://www.w3.org/2001/XMLSchema#string

Rie Tabata

http://www.w3.org/2001/XMLSchema#string

Shingo Kanemura

http://www.w3.org/2001/XMLSchema#string

Takashi Nakano

http://www.w3.org/2001/XMLSchema#string

Tomoyuki Nishizaki

http://www.w3.org/2001/XMLSchema#string

Yoshitaka Nogi

http://www.w3.org/2001/XMLSchema#string

P2860

Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province

Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotype

Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal

Masquerader: high mobility group box-1 and cancer

Occupational, domestic and environmental mesothelioma risks in the British population: a case-control study

TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis

Malignant mesothelioma: facts, myths, and hypotheses

Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma

P2888

1471-2407-13-205

P304

205

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-13-205

http://www.w3.org/2001/XMLSchema#string

P407

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236336978

http://www.w3.org/2001/XMLSchema#string

P6179

1029849268

http://www.w3.org/2001/XMLSchema#string

P698

23617783

http://www.w3.org/2001/XMLSchema#string

P932

3644247

http://www.w3.org/2001/XMLSchema#string